Effects of probucol on xanthomata regression in familial hypercholesterolemia-Reference-Cited by-同舟云学术

Effects of probucol on xanthomata regression in familial hypercholesterolemia

Published:1986-06 Issue:16 Volume:57 Page:H29-H35
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Yamamoto Akira,Matsuzawa Yuji,Yokoyama Shinji,Funahashi Tohru,Yamamura Taku,Kishino Bun-Ichiro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Familial hypercholesterolemia—genetic, biochemical and pathophysiologic considerations;Brown;Adv Intern Med,1975

2. The LDL receptor defect in familial hypercholesterolemia: implications for pathogenesis and therapy;Goldstein;Med Clin North Am,1982

3. Assessment of drug treatment and plasmapheresis in hypercholesterolemia;Yamamoto,1985

4. Effects of colestipol, a new bile-acid sequestering resin, on cholesterol metabolism in man;Miller;J Lab Clin Med,1973

5. Effects of combined drug regimen, cholestyramine and compactin, on heterozygous familial hypercholesterolemia;Yamamoto;Intl J Clin Pharmacol Ther Toxicol,1984

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathophysiology of excess plasma-free cholesterol;Current Opinion in Lipidology;2023-09-25

2. Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022;Journal of Atherosclerosis and Thrombosis;2023-05-01

3. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

4. Dyslipidemias;Dermatology in Public Health Environments;2023

5. Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE);Journal of Atherosclerosis and Thrombosis;2021-02-01